Two small molecules, KL101 and TH301, are the first compounds that selectively target circadian clock components CRY1 and CRY2.
Researchers have successfully created a new, light sensitive, plant-human hybrid protein that efficiently modulates calcium channels.
New technology can rapidly halt or start the expression of genes by shining a light on the cells.
